IS2020B - Bensimídazól efnasambönd, lyfjablöndur sem innihalda efnasamböndin og notkun þeirra - Google Patents

Bensimídazól efnasambönd, lyfjablöndur sem innihalda efnasamböndin og notkun þeirra

Info

Publication number
IS2020B
IS2020B IS4593A IS4593A IS2020B IS 2020 B IS2020 B IS 2020B IS 4593 A IS4593 A IS 4593A IS 4593 A IS4593 A IS 4593A IS 2020 B IS2020 B IS 2020B
Authority
IS
Iceland
Prior art keywords
compounds
pct
phenyl
disorders
sec
Prior art date
Application number
IS4593A
Other languages
English (en)
Other versions
IS4593A (is
Inventor
Teuber Lene
Wätjen Frank
Fukuda Yoshimasa
Ushiroda Osamu
Sasaki Toshiro
Original Assignee
Neurosearch A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch A/S filed Critical Neurosearch A/S
Publication of IS4593A publication Critical patent/IS4593A/is
Publication of IS2020B publication Critical patent/IS2020B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS4593A 1995-04-21 1997-10-17 Bensimídazól efnasambönd, lyfjablöndur sem innihalda efnasamböndin og notkun þeirra IS2020B (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK46095 1995-04-21
DK74195 1995-06-27
PCT/EP1996/001649 WO1996033191A1 (en) 1995-04-21 1996-04-19 Benzimidazole compounds and their use as modulators of the gabaa receptor complex

Publications (2)

Publication Number Publication Date
IS4593A IS4593A (is) 1997-10-17
IS2020B true IS2020B (is) 2005-06-15

Family

ID=26064049

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4593A IS2020B (is) 1995-04-21 1997-10-17 Bensimídazól efnasambönd, lyfjablöndur sem innihalda efnasamböndin og notkun þeirra

Country Status (28)

Country Link
US (1) US5922725A (is)
EP (1) EP0821682B1 (is)
JP (1) JP3171852B2 (is)
KR (1) KR100283363B1 (is)
CN (1) CN1089762C (is)
AT (1) ATE194836T1 (is)
AU (1) AU699623B2 (is)
BR (1) BR9608056A (is)
CA (1) CA2218552C (is)
CZ (1) CZ287538B6 (is)
DE (1) DE69609413T2 (is)
DK (1) DK0821682T3 (is)
EE (1) EE04308B1 (is)
ES (1) ES2150671T3 (is)
GR (1) GR3034558T3 (is)
HK (1) HK1018048A1 (is)
HU (1) HU224031B1 (is)
IS (1) IS2020B (is)
MX (1) MX9708147A (is)
NO (1) NO314502B1 (is)
NZ (1) NZ307532A (is)
PL (1) PL184020B1 (is)
PT (1) PT821682E (is)
RU (1) RU2136676C1 (is)
SK (1) SK282105B6 (is)
TR (1) TR199701219T1 (is)
UA (1) UA54394C2 (is)
WO (1) WO1996033191A1 (is)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1115336C (zh) * 1996-10-21 2003-07-23 神经研究公司 1－苯基－苯并咪唑类化合物及其作为baga－a受体调节剂的用途
WO1998019165A1 (en) * 1996-10-25 1998-05-07 Neurosearch A/S A method for the identification of compounds with anxiolytic potential
GB9702524D0 (en) * 1997-02-07 1997-03-26 Merck Sharp & Dohme Therapeutic agents
WO1999019323A1 (en) * 1997-10-10 1999-04-22 Neurosearch A/S Benzimidazole compounds, pharmaceutical compositions containing the compounds and their use
WO1999029319A2 (en) * 1997-12-09 1999-06-17 Neurosearch A/S Chemical compounds for use as anxiolytic agents and a method for the identification of anxiolytic compounds
WO2000003971A1 (fr) * 1998-07-15 2000-01-27 Meiji Seika Kaisha, Ltd. Procede de production de 2-nitro-fluorobenzenes substitues en position 4
WO2000025780A1 (en) * 1998-10-29 2000-05-11 Bristol-Myers Squibb Company Compounds derived from an amine nucleus that are inhibitors of impdh enzyme
US6281237B1 (en) 1999-04-02 2001-08-28 Neurogen Corporation N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives
US6271241B1 (en) 1999-04-02 2001-08-07 Neurogen Corporation Cycloalkyl and aryl fused aminoalkyl-imidazole derivatives: modulators and GLP-1 receptors
US6380210B1 (en) 1999-04-02 2002-04-30 Neurogen Corporation Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors
US6627624B1 (en) 1999-04-02 2003-09-30 Neurogen Corporation Aryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors
RU2243226C2 (ru) 1999-06-22 2004-12-27 НьюроСёрч А/С Новые производные бензимидазола и содержащие эти соединения фармацевтические композиции
US6642229B2 (en) 2000-05-24 2003-11-04 Merck Sharp & Dohme Ltd. 3-Phenyl-imidazo-pyrimidine derivatives as ligands for GABA receptors
TWI248936B (en) * 2001-03-21 2006-02-11 Merck Sharp & Dohme Imidazo-pyrimidine derivatives as ligands for GABA receptors
JP2004531499A (ja) * 2001-03-23 2004-10-14 メルク シャープ エンド ドーム リミテッド Ｇａｂａ受容体用リガンドとしてのイミダゾ−ピリミジン誘導体
WO2004069160A2 (en) * 2003-01-28 2004-08-19 Smithkline Beecham Corporation Chemical compounds
AU2004226179A1 (en) 2003-04-03 2004-10-14 Neurosearch A/S Benzimidazole derivatives and their use for modulating the GABA-a receptor complex
DE602004011914T2 (de) 2003-04-03 2008-06-12 Neurosearch A/S Benzimidazole derivate und ihre anwendung als gaba a rezeptor komplex modulatoren
TWI391381B (zh) * 2006-03-24 2013-04-01 Neurosearch As 新穎的苯并咪唑衍生物、含有其之醫藥組成物、及其於製造藥物之用途
WO2010055126A1 (en) * 2008-11-14 2010-05-20 Neurosearch A/S Benzimidazole derivatives and their use for modulating the gabaa receptor complex
US8278460B2 (en) * 2009-10-15 2012-10-02 Concert Pharmaceuticals, Inc. Substituted benzimidazoles
US11312715B2 (en) * 2017-09-28 2022-04-26 Cstone Pharmaceuticals (Suzhou) Co., Ltd. Fused ring derivative as A2A receptor inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69224448T2 (de) * 1991-06-24 1998-06-10 Neurosearch As Imidazol-Verbindungen, Verfahren zu ihrer Herstellung und ihre Anwendung
US5158969A (en) * 1991-08-21 1992-10-27 Neurosearch A/S Indole derivatives as potassium channel blockers
DK40192D0 (da) * 1992-03-26 1992-03-26 Neurosearch As Imidazolforbindelser, deres fremstilling og anvendelse
AU675484B2 (en) * 1993-03-24 1997-02-06 Neurosearch A/S Benzimidazole compounds, their use and preparation

Also Published As

Publication number Publication date
EE04308B1 (et) 2004-06-15
ATE194836T1 (de) 2000-08-15
DK0821682T3 (da) 2000-12-04
CN1089762C (zh) 2002-08-28
DE69609413D1 (de) 2000-08-24
CN1182425A (zh) 1998-05-20
JPH11511734A (ja) 1999-10-12
CZ287538B6 (en) 2000-12-13
CZ329197A3 (cs) 1998-03-18
PL184020B1 (pl) 2002-08-30
AU699623B2 (en) 1998-12-10
CA2218552C (en) 2002-04-16
AU5690696A (en) 1996-11-07
NO314502B1 (no) 2003-03-31
SK282105B6 (sk) 2001-11-06
EP0821682B1 (en) 2000-07-19
DE69609413T2 (de) 2000-11-23
MX9708147A (es) 1997-12-31
GR3034558T3 (en) 2001-01-31
US5922725A (en) 1999-07-13
UA54394C2 (uk) 2003-03-17
PL322944A1 (en) 1998-03-02
EP0821682A1 (en) 1998-02-04
PT821682E (pt) 2000-11-30
WO1996033191A1 (en) 1996-10-24
HUP9802272A2 (hu) 1999-09-28
ES2150671T3 (es) 2000-12-01
HK1018048A1 (en) 1999-12-10
KR100283363B1 (ko) 2001-03-02
NO974843L (no) 1997-12-15
EE9700282A (et) 1998-06-15
NO974843D0 (no) 1997-10-20
HU224031B1 (hu) 2005-05-30
SK140697A3 (en) 1998-05-06
RU2136676C1 (ru) 1999-09-10
JP3171852B2 (ja) 2001-06-04
TR199701219T1 (xx) 1998-03-21
HUP9802272A3 (en) 2002-02-28
KR19990007940A (ko) 1999-01-25
CA2218552A1 (en) 1996-10-24
BR9608056A (pt) 1999-11-30
NZ307532A (en) 1999-03-29
IS4593A (is) 1997-10-17

Similar Documents

Publication Publication Date Title
IS2020B (is) Bensimídazól efnasambönd, lyfjablöndur sem innihalda efnasamböndin og notkun þeirra
IS1959B (is) Bensimídazól efnasambönd, lyfjablöndur sem innihalda efnasamböndin og notkun þeirra
ATE316961T1 (de) Heterozyclische derivate für die behandlung von herzversagen und andere erkrankungen
NO980919L (no) 8-azabicyklo(3.2.1)okt-2-ene derivater, og deres anvendelse til fremstilling av et legemiddel
ATE383338T1 (de) N-(phenyl(piperidin-2-yl)methyl)benzamid-deriva e,verfahren zu deren herstellung und ihre therapeutische verwendung
NO921944L (no) Benzofuran-derivater
ATE183496T1 (de) Amidderivate und ihre therapeutische verwendung
NO961404L (no) 4-indolylpiperazinyl-derivater
ATE191465T1 (de) Carbamoylcarbonsäureamide
MX9708096A (es) Compuestos de bencimidazol y su uso para preparar composiciones utiles como moduladores del complejo receptor de gabaa.
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
DK1049670T3 (da) Azetidincarboxamidderivater til behandling af CNS-lidelser
DK0544748T3 (da) Spiro cycloalkylbenzen-1, 1-(1,2,3,4-tetrahydroisoquinoliner) med neurobeskyttende egenskaber
ATE136029T1 (de) Carbostyrylderivate
ATE261433T1 (de) Azadioxacycloalkene derivate, verfahren zu deren herstellung sowie deren verwendung als fungizide und schädlingsbekämpfungsmittel
TH18598A (th) อนุพันธ์ 1,5-เบนโซไดอะเซฟีน